IL6 and metabolic dysfunction-associated steatotic liver disease: Obesity activates the NF-κB pathway and increases the expressions of proinflammatory cytokines such as TNF-α and interleukin-6 (IL-6) in adipose tissue, thereby disrupting insulin signaling and triggering insulin resistance and NAFLD[35].